Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.75%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
4.98 Down 0.05(1.00%) 9:40AM EDT - Nasdaq Real Time Price
Prev Close:5.03
Open:N/A
Bid:4.91 x 600
Ask:5.08 x 100
1y Target Est:9.50
Beta:1.7
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:4.93 - 5.00
52wk Range:3.10 - 7.45
Volume:54,149
Avg Vol (3m):1,402,260
Market Cap:346.38M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXDown 1.00%346.38M
DNDN 0.00%325.73M
NKTRDown 0.45%1.39B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):46.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Jun-14) :-0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback